FERMT1 and nasopharyngeal carcinoma: Recently, FERMT1’s involvement in tumors, including colorectal cancer [11], stomach cancer [12], breast cancer [11, 13]oral squamous cell carcinoma [14], and nasopharyngeal carcinoma [15], has been documented.